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Ig65.-Palmitate-I-04 or glucose-C14( U) was infused intravenously for 4 hr at a constant rate in unanesthetized dogs with indwelling arterial and venous catheters. 02 uptake and CO2 output were measured. Specific activity of CO2 and of plasma FFA or plasma glucose was determined.
Infusion of Na-L( +)-lactate greatly reduced the rate of release and uptake and the rate of oxidation of FFA in normal as well as in pancreatectomized dogs. Lactate decreased also the oxidation of plasma sugar but to a lesser degree. The elevated blood lactate seems to have a glucose-sparing effect in the resting dog. This may lead to accumulation of a-glycerophosphate and may explain the FFA-lowering effect of lactate. Na-n( -)-lactate infused in comparable concentration had no similar effect.
plasma fatty acid turnover; lactate and FFA metabolism; lactate and glucose turnover; lactate and glucose metabolism T HE DISCOVERY that albumin-bound free fatty acids (FFA) are an important energy source, with a rapid turnover rate, raises the question of a possible competition between carbohydrate and FFA in supplying energy to the cells. Such a substrate competition has been intensively investigated in isolated rat diaphragms and in perfused rat heart. Garland, Newsholme, and Randle (5) reported that the addition of ,&hydroxybutyrate or albumin-bound palmitate to the medium significantly reduced the glucose or pyruvate uptake of rat hearts and impaired the oxidation of pyruvate in rat hemidiaphragms. Utilizing a similar preparation, with palmitic acid as the only substrate in the perfusion medium, Olson (14) showed that added pyruvate or acctoacetate decreased the FFA uptake of the rat heart by 50 % and the oxidation of palmitate by 75 %, whereas the formation of neutral lipids was increased five-to sixfold. Williamson (20) studied th e interrelationship between L( +)-lactate and glucose on the heart of rats and found that in the absence of added insulin, lactate contributed more to the respiratory COZ than glucose. With equimolar concentration of both substrates, the oxidation of each was inhibited with a concomitant synthesis of glycogen from glucose.
In vivo, however, such substrate competition may be further complicated by the fact that the accumulation of one of the substrates in the arterial blood may not only suppress the utilization of the other but may also decrease the availability of the competitor. This is clearly the case when the blood glucose level rises. It increases the concentration of insulin in the plasma (6) which in turn depresses the release of FFA from the adipose tissue. Increased levels of blood lactate also depress the release of FFA (7, I 3), and the concentration of blood lactate may under normal conditions show marked variations. Vigorous exercise, for instance, may cause a seven-to eightfold rise in the blood lactate level. In contrast to the effect of glucose, the effect of lactate can also be seen on pancreatectomized dogs in the absence of insulin (I 2). The purpose of the present study was to investigate the effect of lactate infusion on the oxidation of plasma FFA and of plasma glucose.
METHODS
Two or three days before the experiment, indwelling polyethylene catheters (PE 240, Intramedic, ClayAdams) were placed into the left carotid artery and the right jugular vein of normal or pancreatectomized mongrel dogs weighing 12-20 kg. The catheters were filled with physiological saline and kept tightly plugged. No anticoagulant was used. In some of the dogs, pancreatectomy was performed in morphine-Pentothal anesthesia 3-4 weeks prior to the experiment.
After a few days' recovery, the animals were kept on normal Purina dog chow fortified with meat, methionine, and pancreatin tablets. Insulin was given as needed (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) U/day) to prevent glycosuria, but was withheld 48 hr before the experiment. All dogs were trained to lie quietly for 4-5 hr. The experiments were carried out in a postabsorptive state (usually after I 8-hr fasting, unless otherwise stated In experiments with radiopalmitate, the SA of FFA bwhEq) was determined according to the procedure used in our previous studies (I 3). In two of these experiments the plasma was extracted with Folch reagent (2 parts chloroform : I part methanol v/v), and the free fatty acids were separated on silicic acid column according to McCarthy and Duthie ( I 0). Finally, after methylation, the concentration of the individual fatty acids was estimated by means of a Barber-Coleman gas-liquid chromatography unit ( I I ). In these cases, the radioactivity present in the FFA fraction of the plasma (m&ml) was related to the palmitic acid concentration (pEq/ml) to obtain the SA of palmitate. about 600 counts/min per 2 ml, no measurable radioactivity (less than twice the background) was found in the second eluate. All radioactivities were counted in a TriCarb liquid-scintillation counter at 3-2 C and at an efficiency of about 68 %. When glucose-Cl4 was used as a tracer, the experiment started with a priming dose of I .6-2.0 &kg followed by a constant infusion of about I 7 m&kg min. The SA of plasma glucose was measured as follows : I .5-2 g of Amberlite o (Rohm and Haas, Philadelphia, Pa.) was ground, thoroughly washed, and filled in columns; IO ml of the protein-free filtrate (Ba(OH)2 and ZnS04 precipitation) obtained from 2 ml plasma was placed on the resin columns. The eluate contained all the glucose whereas lactate and other acids were retained on the column.
At blood lactate concentrations ranging from 8 to 85 mg/~ oo ml the eluate contained less than 4 % of the lactate originally present in the blood. Two milliliters of the eluate was placed in a counting vial containing I 5 ml Bray solution (2). The radioactivity of the samples was counted; then 50 ~1 C14-labeled benzoic acid (representing 2,950 dpm) was added to each vial, and the samples were recounted.
The counts were corrected for quenching and expressed as millimicrocuries per milliliter of eluate. The glucose content of the eluate was then determined with the Glucostat method. In three control experiments (without lactate infusion) the lactic acid was eluated from the resin with 25 ml o. I M NaCl, and 2-ml anquots were assayed for radioactivity and lactic acid concentration.
When the first eluate (glucose) carried Cahlations. When radiopalmitate was used as a tracer, each experiment was divided into two phases. Phase I extended from the injection of the priming dose at zero time (which was immediately followed by the constantrate infusion) to the I 10th min. Five to ten times the amount of radioactivity infused per minute was given in the,form of a single injection as a priming dose. Within that range the ratio did not seem to be critical.
It did not affect the course of specific activities in the plasma or in the expired air. Measurements made at 60, 75, go, and I05 min were used for the calculation of base-line values. At the I 10th min, the intravenous infusion of Na-lactate (pH: 7.4) was started, and this was continued for 45 min. As the result of this, the plasma FFA rapidly decreased and the SA of FFA rose; it reached a new plateau and remained constant until the end of the experiment (usually 230 min). Values obtained between the I 50th and 230th min were used for the calculation of the new equilibrium designated as phase II. The production and removal rates of plasma FFA (pEq/kg min) were calculated from the infusion rate of radiopalmitate (m&kg min), the changes of the FFA pool (assuming an FFA space of 50 ml/kg), and the changes of the FFA SA, according to the eq" .ations worked out by Steele (I 6 ) as they were used in our previous studies (8). It should be pointed ou t that a Where CO2 SAt = m is the asymptote, CO2 SAt is the specific activity measured at time t (min), and Ft is the time factor :
This asymptotic value represents an equilibrium between the SA of exhaled CO2 and the SA of COZ arising from tissue oxidations.
In phase I, CO:! SAt = a was calculated from each of the values measured between the 60th and 105th min (X on Fig. I ), and its mean value was used to construct the theoretical curve of CO2 SA ( 0 . 9 l 0 on Fig. I ). The use of the mean values appeared justifiable since there was no consistent difference in the asymptotic value whether it was calculated from the fourth sample (at the 105th min) or from the first sample (at the 60th min). In seven experiments the fourth sample, and in five experiments the first sample, gave somewhat higher asymptotic values, but in any case the deviation from the mean values was within the error of the single determination (~t5 %). The asymptotic SA of COB was then related to the mean SA of the plasma FFA, assuming an average chain length of I 7 carbon atoms (or 16 carbon atoms if it was related to the SA of palmitic acid only), to obtain the percent CO2 derived from the FFA. This value multiplied by the CO2 output (mmole/kg min) and divided by I .7 gives the amount of plasma FFA (pEq/kg min) directly oxidized, which can be expressed also in percent of the FFA turnover rate.
Phase II was characterized by an elevated FFA SA. This was brought about either by the lactate infusion (inhibition of rate of release of FFA) or in the control experiments simply by increasing the infusion rate of the tracer. In this latter case, the CO2 SA continued to rise, and the curve of phase II (CO, SArl) was superimposed on the curve of phase I (COa SAI) approaching a new asymptotic value ( CO2 SAF-,) . In control experiments, we may assume that the oxidation of FFA in phase I is the same as in phase II, and therefore 
where F: is the time factor for the time from the priming dose (t = o) until the collection of the sample. Following the increase of the infusion rate of the tracer at the I I 0th min, the SA of FFA rose quickly. Since in phase II no priming dose was used, 20 min was required to reach the new steady state (I ). The best agreement between measured and calculated values of CO2 SAf was obtained when in phase II a I 5-min delay was applied in taking zero time. Therefore, for phase II the time factor was E(110+16) l 2
The calculated course of CO2 SAII (Fig. I , 0 l l l 0) was then compared with the actually measured values (Fig. I, X) ; the deviation was expressed in percent of the 2 For example, in the experiment shown in Fig. I it tends to reduce the problem caused by the body bicarbonate pool by relating the CO2 SA measured at any given time to the ideal situation in which the exhaled CO2 is of the same SA as the CO2 arising from the body's soft tissues.
In experiments with glucose-C14, essentially the same line of calculations was followed, with two differences. First, the glucose pool was estimated from the priming dose (t = o) and the average glucose SA in the plasma (between teO and tIIo) as suggested by Steele et al. (I 7) . If the plasma sugar changed in the course of the experiment, 50 % of this change was taken into account in the estimation of the rate of hepatic glucose output and the rate of removal of sugar (both in pmole/kg min). Second, since the glucose SA did not show such dramatic changes as seen in the FFA SA, it was not necessary to divide the experiment into two phases. Instead, the mean value of CO2 SAt = oo was calculated from four measurements obtained between tso and tllo. Then the expected value of CO2 SA t at any given time (between tllo and t& was obtained from equation I by multiplying Cn SAt = 00 by Ft. The effect of lactate was estimated fr the difference between the expected and measured viz. (percent inhibition of the oxidation of plasma glucose). The COZ SAt = o. divided by the glucose SA and multiplied by 600 (6 COz from the uniformly labeled glucose) gave the percent COs derived from the oxidation of plasma glucose. This value multiplied by the CO2 output (mmole/kg min) and by the factor I .66 (IO/~) gave the amount of plasma glucose immediately oxidized (pmole/ kg min). The difference between the rate of removal and the rate of oxidation was designated as glucose "retained."
RESULTS
Experiments with palmitate-r-C14
as tracer. Figure 2 shows the effect of Na-Q-j-)-lactate infusion.
The base-line values of FFA metabolism in this dog were in the low range (phase 1). The plasma FFA level was 0.54 pEq/ml with a turnover rate of 15.0 pEq/kg min, 2 I .4 % of which (3.4 pEq/kg min) was immediately oxidized, contributing only about 20 % of the expired C02. The lactatc infusion Qhase 11) started at the I 10th min. The 4o-min infusion raised the blood lactate to the moderate level of 54 mg/I oo .ml. Plasma FFA decreased rapidly, and at the same time the FFA SA rose from 1.35 mpc/ ,uEq to a new level of I .g6 mpc/pEq.
The rate of release of FFA decreased in IO min to 12 pEq/kg min and the rate of removal exceeded this value by I .2 pEq/kg min. From the I 20th min on, there were negligible differences between the rate of release and the rate of uptake. The calculated turnover rate was I I pEq/kg min (a decrease of 3 I %). The slow rising course of CO, SA was interrupted, and in spite of the rise in the FFA SA, the SA of CO2 fell from I I to 8 m&mmole. Had the rate of FFA oxidation remained the same, the increase in FFA SA should have induced a further rise of COz SA, as calculated according to equation 4 (Fig. 2 , 0 and the 0). The difference between the measured values expected course of CO2 SA revealed a 42-51% inhibition of the FFA oxidation, from 3.4 pEq/kg min to an average of I .8 pEq/kg min.
As previously reported ( I 2), lactic acid also strikingly depresses the turnover rate of FFA in pancreatectomized dogs. Figure 3 shows that it also decreases the oxidation of FFA; in that dog, lactic acid infusion raised the lactate level to 77 mg/I oo ml, and the characteristically high turnover rate of the diabetic dog was decreased from 38 to about 17 pEq/kg min. This was accompanied by a 55-59 % reduction of the rate of oxidation of plasma FFA from 9.8 to 4.7 pEq/kg min. Prior to the lactate infusion, the immediate oxidation of FFA contributed some 4g % to the exhaled COZ, and this value dropped to I 7 %. course of CO2 SA and the actually measured values did not exceed ~8 % in any of these experiments. Lactic acid infusion strikingly decreased the turnover rate by 130-60 %I. The effect seems to depend not only on the blood lactate level but also on the preinfusion value of the FFA turnover rate. In order to increase the range of FFA turnover, on which the effect of lactate could be tested, two animals-one for a control, and one for a lactate infusion-were fasted for 48 hr instead of the usual 18 hr. In general, it appeared that the higher the initial turnover rate the more striking was the effect of lactate infusion.
As the turnover rate decreased, the oxidation of FFA, and consequently its contribution to the total CO2 output, also declined.
In two experiments, the plasma FFA were analyzed by gas chromatography, and the rates of turnover and oxidation of palmitic acid were separately calculated ( for total FFA were 35 and 38.7 %, respectively. As pointed out earlier (I 2), the FFA-depressing effect of lactate could also be seen in pancreatectomized dogs. Table I shows that even when the blood lactate level was increased only to 3 I mg/~ oo ml, a definite reduction in the rates of oxidation and turnover of FFA could be observed. With higher lactate concentration, a greater depression developed.
One of the pancreatectomized dogs (dog 7) received I .2 U/kg long-acting insulin 24 hr prior to the experiment.
The following day the plasma concentration of glucose, FFA turnover, and rate of oxidation of FFA were all in the normal range. Lactate infusion which increased the blood lactate level to 73 mg/I oo ml had a dramatic effect. It reduced the FFA turnover rate by 60 % and the rate of oxidation by 6g %.
The percent contribution of plasma glucose to exhaled CO2 was definitely decreased in all experiments, and at the same time the rate of removal of glucose was somewhat increased, in this case from 14.4 to 16.2 pmoles/kg min. Prior to the lactate infusion, 4.2 pmoles/kg min plasma glucose was immediately oxidized and 10.2 pmoles/kg min entered pathways other than the Krebs cycle. At the end of the lactate infusion only 3. I pmoles/ kg min of the plasma glucose was oxidized and 13. I pmoles/kg min was retained, whereas in the postinfusion phase this value decreased again to 10.4 pmoles/kg min. Table  2 summarizes the results obtained with uniformly labeled glucose. In each experiment four measurements were made between the 60th and I 10th min. The mean of these values was used to calculate the group averages and their standard errors (SE) . For the period of elevated blood lactate the rate of entry and the rate of removal of glucose were estimated in each experiment from the mean values of four subsequent measurements obtained between the I I 0th and I 70th min (see Fig. 4 ). The differences between these two periods were then averaged and the mean *SE was shown in the table. As to the glucose oxidation, the deviations from the individual initial values were calculated for each sample separately. The estimation of the rate at which glucose was retained was based on the mean rate of removal measured during the second period. The mean changes obtained at the 150th min (highest blood lactate) were used for statistical evaluation.
This latter was carried out according to the Fisher t test of significance as applied for paired variates. The value of P (= probability of chance differences from initial values) was shown only when it was less than 0.02.
Experiments with radiaactioe glucose. A total of 16 experiments was carried out on normal dogs, 12 with Na-L(+)-lactate and 4 with Na-D( -)-lactate. In addition, the effect of Na-L(+)-lactate was studied in five pancreatectomized dogs. Figure 4 shows in detail the effect of L(+)-lactate on the rate of removal and the rate of oxidation of plasma glucose in one of the normal dogs. The blood lactate was increased to 7g mg/~oo ml, the plasma sugar showed a moderate decline (from I 08 to 8g mg/Ioo ml), whereas the SA of plasma glucose did not change appreciably.
It should be noted that there were some variations in these responses. In 6 out of the 12 experiments, the plasma glucose level was decreased by more than 5 mg/r oo ml. In four dogs the changes were less than rt5 mg/I oo ml, and in two experiments the level increased by more than 5 mg/r oo ml. The glucose SA showed no marked changes (less than =t I o % of the initial values) in seven experiments, and in five dogs there was a definite decrease of more than IO %.
The CO2 SA showed, on the other hand, a rather uniform response. Its rising course was invariably interrupted by lactate infusion, and at the end of the infusion it was 22 % below the expected value (Fig. 4, 0 . l . 0). As the blood lactate slowly decreased, the CO2 SA rose again in the postinfusion recovery period.
As previously stated, Na-L( +)-lactate decreased the plasma FFA level in normal as well as in pancreatectomized dogs, whereas Na-D( -)-lactate at a comparable blood lactate level failed to induce any significant change. In contrast to the striking reduction of the release of FFA, the rate of glucose entry (hepatic sugar output) was not decreased. The rate of removal of glucose was rather consistently increased (P < .OOI), on the average by about 20 %. This increase in peripheral sugar uptake was met by a corresponding increase of the hepatic output in some dogs but not in others. This seemed to cause the inconsistency in the response of plasma glucose level. In the four experiments conducted with n(-)-lactate, the rate of glucose entry was slightly decreased and the rate of removal slightly increased. None of these changes was statistically significant, but the combination of these two responses caused a statistically significant decrease in the plasma sugar level (a discrepancy.
of 2 pmoles/kg min between inflow and outflow over a period of 40 min is sufficient to cause a IO % decrease of plasma glucose level).
In whereas it depressed the oxidation of glucose led to an almost 50 % increase (P < .oor) of the amount of glucose removed but not oxidized.
In 12 experiments, lactate infusion saved, on an average, 4.9 pmoles/kg min glucose from immediate oxidation.
In the pancreatectomized dogs, the hepatic glucose output was almost three times higher (49 pmoles/kg min) than in the normal animals, but only about IO % of this (5. I pmoles/kg min) was directly oxidized, contributing only 9.5 % to the expired CO,. Unfortunately, the rate of removal of glucose and the glucose-sparing effect of lactate could not be estimated because of the loss of sugar in the urine. However, infusion of L(+)-lactate also depressed the oxidation of glucose in these animals (P < .02). This indicates that lactate entered the cells and effectively competed with glucose for entry into the Krebs cycle. than in that of glucose seemed to be due to the fact that the lactate caused a marked reduction in the rate of release of FFA, presumably from the adipose tissue. This interpretation was based on two observations: a) The reduction of FFA oxidation persisted also in the postinfusion period when the blood lactate was approaching the base-line values, whereas the depression in glucose oxidation was restricted only for the period of elevated blood lactate. Following this, glucose oxidation rose above the initial value (Table 2) ; b) The depression of release of FFA led to a decrease in the plasma concentration of FFA with a concomitant reduction in the rate of uptake ( I, 8), and the rate of oxidation was decreased proportionally.
In other words, essentially the same fraction of FFA uptake was converted to CO, during the preinfusion period (avg 28.5 Y) as in the new steady state after lactate infusion (2 g YO ) .
DISCUSSION
This study showed that infusion of Na-L(+)-lactate decreased the rate of oxidation of both FFA and plasma glucose. During lactate infusion the Cr402 SA decreased regardless of whether radioglucose or radiopalmitate was used as tracer. This indicates that the lactate was readily oxidized and the resulting unlabeled CO2 diluted the radioactivity in the expired air. However, the oxidation of plasma FFA was reduced by 40-60% whereas the oxidation of plasma glucose was decreased only by [15] [16] [17] [18] [19] [20] [21] [22] % (avg 18 Yo).
The greater depression in the oxidation of plasma FFA In contrast to the striking effect on the release of FFA, the hepatic glucose output did not show a consistent response. However, the rate of glucose removal was consistently but only slightly increased (+20 o/o) .
In this connection the question arises if a possible recycling of the label in the form of a C3 unit (liver glucose formation from labeled lactate and pyruvate, via the Cori cycle) could explain such a finding.
With the constant-rate infusion technique, such .a recycling of Cl4 would be expected to produce a slow rise of the glucose SA in the course of the experiment.
Such a rise was not seen, however.
Strisower and Searle (I 8) found that the SA of plasma glucose was rather constant for 7 hr. Simi- In connection with-the present study, four control experiments were carried out without lactate infusion.
Up to I 70 min, the SA remained constant in all animals, and after that only one dog showed a 5 % increase.
It should be pointed out that only a recycling which occurred prior to the lactate infusion (before the I I 0th min) could lead to an error in the calculation of glucose entry and removal.
In that case the elevated blood lactate would decrease the SA of the hepatic glucose and this could be interpreted as an increase of the rate of entry of glucose. However, this would require a rather high SA of the blood lactate (close to the glucose SA) and the assumption of a high rate of gluconeogenesis from lactate. As mentioned above, under the condition of the present study the amount of radioactivity present in the lactate seemed to be negligible.
Although no evidence of an appreciable recycling was found, further studies are needed to verify the effect of lactate on the rate of glucose production and uptake.
